TRACE. Real-life clinical use of tralokinumab Observational cohort study of patients with atopic dermatitis prescribed tralokinumab.
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: LEO PHARMA A/S
- Execution start: 18/10/2022
- End of execution: 30/12/2024
- PI: SALVADOR ARIAS SANTIAGO
